Stay Up to Date
with SHINE

SHINE announced today that it will host a key opinion leader (KOL) meeting on the topic of Nuclear Medicine and Diagnostics on June 15th in New York City.

SHINE and Rock Creek Innovations to Partner on Design and Implementation of Instrumentation and Control Protection Systems for Medical Isotope Plant

SHINE announced today that it will grant the Boys & Girls Club of Janesville $5,000 for its new STEM Lab.

After breaking ground in August of 2017, JP Cullen completed the 6-month construction project three weeks ahead of schedule and on budget, with zero OSHA-recordable incidents.

Molybdenum-99 is a cancer-detecting necessity, but it decays within days and isn’t made in North America. A company is rushing to build a plant in Wisconsin to change that.

The isotope is a cancer-detecting necessity, but it decays within days and isn’t made in North America. A company is rushing to build a plant in Wisconsin to change that.

Building One construction continues on schedule! Over 60 on-site work days with 0 accidents.

SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 9,734,926.

SHINE Selects Baker Concrete Construction as Prime Contractor for Medical Isotope Production Facility Project

SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, held a groundbreaking ceremony yesterday to celebrate the start of construction on Building One.

SHINE Medical Technologies, Inc. announced today that it Med as part of a $20.9 million cooperative agreement.

SHINE Medical Technologies, Inc. (SHINE), announced plans to move its headquarters from Monona to downtown Janesville, Wisconsin late this year.

The supply agreement, which marks HTA’s first with a U.S. supplier of moly-99, demonstrates both companies’ ongoing commitment to ensuring that the medical imaging community has reliable and secure access to moly-99 to meet the needs of patients.

Phoenix Nuclear Labs (PNL) and SHINE Medical Technologies (SHINE) announced today that they successfully operated their accelerator-based neutron generator for 132 consecutive hours with greater than 97% uptime.

U.S. Nuclear Regulatory Commission (NRC) has authorized the issuance of the SHINE construction permit